Chemotherapeutic options in HIV infection.
Cox
S
S
Virology Dept, Swedish Institute for Infectious Disease Control, Karolinska Institute, Stockholm.
Palmer
S
S
Aperia
K
K
Wahren
B
B
D000704:Analysis of Variance; D000998:Antiviral Agents / Q000494:pharmacology*; D001711:Biotransformation; D002460:Cell Line; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D016049:Didanosine / Q000378:metabolism / Q000494:pharmacology*; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D006679:HIV Seropositivity / Q000821:virology; D015497:HIV-1 / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D008214:Lymphocytes / Q000821:virology; D008826:Microbial Sensitivity Tests; D014407:Tumor Cells, Cultured; D015215:Zidovudine / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use
D000998:Antiviral Agents; D015215:Zidovudine; D016049:Didanosine